BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12038453)

  • 21. Is the determination of anti-beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome?
    Hsieh K; Knöbl P; Rintelen C; Kyrle PA; Quehenberger P; Bialonczyk C; Partsch H; Lechner K; Pabinger I
    Br J Haematol; 2003 Nov; 123(3):490-5. PubMed ID: 14617012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Samarkos M; Davies KA; Gordon C; Loizou S
    Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity.
    Carmo-Pereira S; Bertolaccini ML; Escudero-Contreras A; Khamashta MA; Hughes GR
    Ann Rheum Dis; 2003 Jun; 62(6):540-3. PubMed ID: 12759291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations.
    Tektonidou MG; Petrovas CA; Ioannidis JP; Vlachoyiannopoulos PG; Moutsopoulos HM
    Eur J Clin Invest; 2000 Jul; 30(7):646-52. PubMed ID: 10886305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus.
    Amoroso A; Mitterhofer AP; Del Porto F; Garzia P; Ferri GM; Galluzzo S; Vadacca M; Caccavo D; Afeltra A
    Hum Immunol; 2003 Feb; 64(2):265-73. PubMed ID: 12559629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of beta2-glycoprotein I IgG and IgM antibodies with thrombosis and thrombocytopenia.
    Voss A; Jacobsen S; Heegaard NH
    Lupus; 2001; 10(8):533-8. PubMed ID: 11530994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension.
    Martinuzzo ME; Pombo G; Forastiero RR; Cerrato GS; Colorio CC; Carreras LO
    J Rheumatol; 1998 Jul; 25(7):1313-9. PubMed ID: 9676762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary embolism and transitory anti-beta2-GPI antibodies in an adult with chicken pox.
    Viseux V; Darnige L; Carmi E; Chaby G; Poulain JF; Cevallos R; Lok C; Denoeux JP
    Lupus; 2000; 9(7):558-60. PubMed ID: 11035426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the anti-beta2-glycoprotein I antibody provide additional information in patients with thrombosis?
    Lee EY; Lee CK; Lee TH; Chung SM; Kim SH; Cho YS; Yoo B; Moon HB
    Thromb Res; 2003; 111(1-2):29-32. PubMed ID: 14644075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome.
    Zachou K; Liaskos C; Christodoulou DK; Kardasi M; Papadamou G; Gatselis N; Georgiadou SP; Tsianos EV; Dalekos GN
    Eur J Clin Invest; 2003 Feb; 33(2):161-8. PubMed ID: 12588291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiphospholipid Antibodies Are Not Associated with Clinical Parameters or Prognostic Outcomes in Patients with Non-Hodgkin's Lymphoma.
    Pal R; Varma S; Ahluwalia J; Prakash G
    Hamostaseologie; 2020 Dec; 40(5):662-670. PubMed ID: 32932545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel enzyme immunoassay system for simultaneous detection of six subclasses of antiphospholipid antibodies for differential diagnosis of antiphospholipid syndrome.
    Nojima J; Motoki Y; Hara K; Sakata T; Ichihara K
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):316-322. PubMed ID: 27676644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro.
    Nojima J; Kuratsune H; Suehisa E; Kitani T; Iwatani Y; Kanakura Y
    Thromb Haemost; 2004 May; 91(5):967-76. PubMed ID: 15116258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus.
    Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis.
    Harrison CN; Donohoe S; Carr P; Dave M; Mackie I; Machin SJ
    Thromb Haemost; 2002 May; 87(5):802-7. PubMed ID: 12038780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
    Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y
    Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined search for anti-beta2-glycoprotein I and anticardiolipin antibodies in antiphospholipid syndrome: contribution to diagnosis.
    Sanmarco M; Roll P; Gayet S; Oksman F; Johanet C; Escande A; Cohen JH; Chevailler A; Goetz J; Humbel RL; Sibilia J
    J Lab Clin Med; 2004 Sep; 144(3):141-7. PubMed ID: 15454883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.